WCM Investment Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
WCM Investment Management's ATRC Position: Q1 2026 in Review
WCM Investment Management reduced its AtriCure (ATRC) stake by 3.5% in Q1 2026, selling an estimated $441K and leaving 359,761 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #145.
WCM Investment Management first reported a position in ATRC in Q1 2019 and has held it in 29 quarters since. The position peaked at $15M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- WCM Investment Management held 359,761 shares of AtriCure worth $10.2M as of Q1 2026.
- WCM Investment Management sold 12,921 AtriCure shares in Q1 2026, an estimated $441K.
- AtriCure made up 0.02% of WCM Investment Management's portfolio in Q1 2026, its #145 holding.
- WCM Investment Management first reported a position in AtriCure in Q1 2019 and has held it in 29 quarters since.
- WCM Investment Management's AtriCure position peaked at $15M in Q4 2025.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.